Kyuho Han

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Blood advances

Nature communications

Cancer research

Nature

MEDIC Life Sciences

Stanford University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

MEDIC Life Sciences Apr 01 2020

United States

CEO/Founder

Stanford University May 05 2014 - Apr 01 2020

United States

Postdoc :: Genetics

Education History

Stanford University Sep 01 2007 - Mar 29 2014

United States

PHD :: Chemical & Systems Biology

Korea Advanced Institute of Science and Technology Mar 01 2000 - Feb 28 2006

South Korea

BSC :: Biological Science

Publications

Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances (2024)
Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael C Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances 8 (11) (2024)
Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael C Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances 8 (11) (2024)
Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael C Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances 8 (11) (2024)
Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael C Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances 8 (11) (2024)
Masanori Yoshinaga, Kyuho Han, David W Morgens, Takuro Horii, Ryosuke Kobayashi, Tatsuaki Tsuruyama, Fabian Hia, Shota Yasukura, Asako Kajiya, Ting Cai, Pedro H C Cruz, Alexis Vandenbon, Yutaka Suzuki, Yukio Kawahara, Izuho Hatada, Michael C Bassik, Osamu Takeuchi
The N 6 -methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity. Nature communications 13 (1) (2022)
Riaz Gillani, Bo Kyung Alex Seong, Jett Crowdis, Jake R Conway, Neekesh V Dharia, Saif Alimohamed, Brian J Haas, Kyuho Han, Jihye Park, Felix Dietlein, Meng Xiao He, Alma Imamovic, Clement Ma, Michael C Bassik, Jesse S Boehm, Francisca Vazquez, Alexander Gusev, David R Liu, Katherine A Janeway, James M McFarland, Kimberly Stegmaier, Eliezer M Van Allen
Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival. Cancer research 81 (15) (2021)
Marcus R Kelly, Kaja Kostyrko, Kyuho Han, Nancie A Mooney, Edwin E Jeng, Kaitlyn Spees, Phuong T Dinh, Keene L Abbott, Dana M Gwinn, E Alejandro Sweet-Cordero, Michael C Bassik, Peter K Jackson
Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities. Cancer discovery 10 (12) (2020)
Kyuho Han, Sarah E Pierce, Amy Li, Kaitlyn Spees, Grace R Anderson, José A Seoane, Yuan-Hung Lo, Michael Dubreuil, Micah Olivas, Roarke A Kamber, Michael Wainberg, Kaja Kostyrko, Marcus R Kelly, Maryam Yousefi, Scott W Simpkins, David Yao, Keonil Lee, Calvin J Kuo, Peter K Jackson, E Alejandro Sweet-Cordero, Anshul Kundaje, Andrew J Gentles, Christina Curtis, Monte M Winslow, Michael C Bassik
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities. Nature 580 (7801) (2020)
David W Morgens, Michael Wainberg, Evan August Boyle, Oana Ursu, Carlos L Araya, C Kimberly Tsui, Michael S Haney, Gaelen T Hess, Kyuho Han, Edwin E Jeng, Amy Li, Michael P Snyder, William J Greenleaf, Anshul Kundaje, Michael C Bassik
Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens. Nature communications 8 (2017)

Kyuho Han.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kyuho Han